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ABSTRACT 
There are various parameters like solubility, stability, compatibility, excipient, and photostability which affects formulation of drugs, but 
solubility plays an important role for drug formulation. Most of newly discovered drugs are poorly water soluble. The poor water solubility of 
drugs always create major problem during drug formulation. There are many conventional techniques available for increasing the solubility of 
poorly soluble drugs such as micronization, solubilisation using co‐solvents, salt form, precipitation technique etc. Other newer methods are 
also available such as liposomes, emulsions, microemulsion, solid dispersion but they lack in general applicability to all drugs. These techniques 
are not applicable for those drugs which are not soluble in aqueous and organic solvents. Poorly water-soluble compounds are difficult to 
develop as drug products using conventional formulation techniques. Nanotechnology is emerging trend to develop the formulation of those 
drugs which are poorly water soluble. Nanotechnology involves particle size ranges from 1–1000 nm. The reduction of drug particle size into 
the submicron range automatically leads to increase in the dissolution rate and therefore enhances bioavailability. Nanosuspe nsion technology 
is effective new way that can be used for enhancing the dissolution of poorly water soluble drugs. A nanosuspension solves the problems of 
poor solubility and bioavailability as well as alters the pharmacokinetics of drug and this will improve drug safety and efficacy. Another 
additional feature of nanosuspensions is that they may induce changes in the crystalline structure, increasing the amorphous fraction in the 
particle or even sometimes creating completely amorphous particles.  
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INTRODUCTION 
Nanotechnology is defined as the science and engineering 
carried out in the nanoscale that is 10–9 m1. Nanotechnology 
is the science and technology of precisely describes the 
structure of matter at the molecular level. Nanosuspensions 
are colloidal dispersions and biphasic system consisting of 
particles dispersed in an aqueous vehicle in which the 
diameter of the suspended particle is less than 1um in size2. 
The unique features of nanosuspensions have enabled their 
use in various dosage forms8. The nanosuspensions can be 
used to formulate compounds that are insoluble in both 
water and oils12. The particle size distribution of the solid 
particles in nanosuspensions is usually less than one micron 
with an average particle size ranging between 200 and 600 
nm5. Nanosuspensions vary from nanoparticles and solid 
lipid nanoparticles. Nanoparticles are usually polymeric 
colloidal transporters of drugs whereas solid lipid 
nanoparticles are lipid carriers of drugs. In nanosuspension 
technology, the drug is continued in the required crystalline 
state with reduced particle size, leading to an improved 
dissolution rate and therefore enhanced bioavailability7. 
Nanosuspensions consist of the poorly water soluble drug 
which is frequently suspended in dispersion. These can be 
used to enhance the solubility of drugs that are poorly 
soluble in aqueous as well as lipid media3. The 
nanosuspension formulation can be applied to all drug 
compounds belonging to biopharmaceutical classification 
system (BCS) classes II andIV to increase their solubility4. 
Preparation of nanosuspension is simple. There are various 
techniques available to prepare nanosuspensions such as 
wet mill, high pressure homogenizer, emulsion solvent 
evaporation, melt emulsification and supercritical fluid 
techniques7. Nanosuspensions differ from nanoparticles 
which are polymeric colloidal carriers of drugs4. 
Nanosuspensions can be applied by parenteral, oral, ocular 
and pulmonary routes. Currently, efforts are being directed 
to extending their applications in site-specific drug delivery8. 
Advantages of nanosuspension 
• It enhances the solubility and bioavailability of drugs 
• By nanosuspension approach higher drug loading can be 
achieved 
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• It enhances the physical and chemical stability of drugs 
• It provides a passive drug targeting 
• It is suitable for hydrophilic drugs 
• Dose reduction is possible 
• Larger drug loading can also be done 
When to go for nanosuspension approach? 
 Nanosuspension is preferred for the compounds that are 
insoluble in water. 
 Compounds with high log P value. 
 Compounds having high melting point and high dose2. 
FORMULATION CONSIDERATIONS FOR 
NANOSUSPENSIONS: 
Nanosuspension formulation requires basically stabilizer or 
surfactant, proper solvent system and others ingredients for 
its preparation7. 
a) Stabilizers:  
Use of stabilizers is essential in formulation of 
nanosuspensions. In the absence of an appropriate stabilizer, 
the high surface energy of nano-sized particles can induce 
agglomeration or aggregation of the drug crystals. This will 
provide high physical instability therefore use of stabilizer is 
required in nanosuspension formulation. Eg. Polysorbate, 
(Tween/Span series), povidone, poloxomers and lecithin3,5,7.  
b) Organic solvent:  
Organic solvents are generally used in preparation of 
nanosuspension if basic technologies such as emulsion or 
microemulsions are used as template for this.These solvents 
are very hazardous in physiologic and environmental means 
but still some less hazardous water miscible solvents like 
methanol, ethanol are used.The use of organic solvents in the 
pharmaceutical area depends upon their toxicity potential 
and the ease of their removal from the formulation 3,7,10. 
c) Surfactants:  
Surfactants are incorporated to reduce interfacial tension of 
particles and thereby to produce a smooth dispersion.They 
also used as wetting or deflocculating agents e.g. Tweens and 
Spans - widely used surfactants5, 6. 
d) Co-surfactants: 
The choice of co-surfactant becomes critical when using 
microemulsions to formulate nanosuspensions. Co-
surfactants greatly influence phase behavior. Therefore the 
effect of co-surfactant on uptake  of the  internal  phase  for  
selected  microemulsion composition  and  on  drug  loading  
should  be investigated.e.g.  Transcutol, glycofurol, ethanol 
and iso-propanol - safely  used as co-surfactants. Also, bile 
salts and Dipotassium glycerrhizinate can be used as co-
surfactants3,5,6. 
e) Other additives: 
Uses of other ingredients mainly depends upon either the 
route of administration or physicochemical properties of 
drug candidate but some additives such as buffers, salts, 
polyols, osmogent and cryoprotectant are normally 
used.Other additives such as buffers, salts, polyols, osmogent 
and cryoprotectant,  depending  on  either the  route  of 
administration  or  the  properties  of  the  drug moiety5,7. 
METHODS OF PREPARATION OF NANOSUSPENSION 
Technically nanosuspensions preparations are simpler than 
liposome’s preparation and other conventional colloidal drug 
carriers but they are more cost effective. Nanosuspension 
approach is used particularly for poorly soluble drugs and to 
yield a physically more stable product. For manufacturing 
nanosuspensions there are two converse methods available 
viz. “Top-down process technology” and “Bottom-up process 
technology”.  
The top -down process follows disintegration approach from 
large particles, microparticles to Nanosized particles.  
Examples are following; 
High pressure homogenization  
Nanoedge 
Nanopure 




Figure 1: Approaches for preparation of nanosuspensions 
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Bottom-up process is an assembly method which also forms 
nanoparticles from molecules. Examples includes  
Solvent-Antisolvent method  
Super critical fluid process  
Emulsification Solvent evaporation technique  
Lipid emulsion/Micro-emulsion template.  
1. BOTTOM UP TECHNIQUES 
The principle techniques generally used in recent years for 
preparing nanosuspensions are:  
A .High pressure homogenization:  
This technique has been used to prepare nanosuspension of 
many poorlywater soluble drugs.It involves three steps. First 
drug powders are dispersed in stabilizer solution to form 
presuspension, and then the presuspension. International is 
homogenized in high pressure homogenizer at a low 
pressure for premilling, and finally homogenized at high 
pressure for 10 to 25 cycles until the nanosuspensions of 
desired size are formed. Different methods are developed 
based on this principle for preparations of nanosuspensions 
are Disso cubes, Nanopure, Nanoedge and Nanojet5,7. 
a. Homogenization in aqueous media (Disso cubes):  
Disso cubes technology was developed by R.H.Muller. He 
used a piston-gap type high pressure homogenizer in 1999. 
The suspension containing a drug and surfactant is forced 
under high pressure through a Nanosized aperture valve of a 
high pressure homogenizer.The instrument can be operated 
at  pressure ranging  from 100-1500 bars (2800-21300 psi) 
and  up  to  2000  bars  with  volume capacity  of  40  ml  (for  
laboratory  scale). 
Principle:  
This method is based on cavitation principle. In this method 
the dispersion containing drug and surfactant present in 
3cm diameter cylinder is suddenly passed through a very 
narrow gap of 25μm.According to Bernoulli’s law the flow 
volume of liquid in a closed system per cross section is 
constant. This results in increase in dynamic pressure and 
decrease of static pressure below the boiling point of water 
at room temperature due to reduction in diameter from 3cm 
to 25μm, then water starts boiling at room temperature 
which results in formation of gas bubbles, which implode 
when the suspension leaves the gap (called cavitation) and 
normal air pressure is reached. The particles cavitation 
forces are sufficiently high to convert the drug micro 
particles into nanoparticles5, 7. 
Advantages 
1. It prevents erosion of processed materials  
 2. The method can be applied to the drugs that are poorly 
soluble in both aqueous and organic media.  
Disadvantages 
1. Pre-processing like micronization of drug is required.  
2. High cost instruments are required that will also increases 
cost of dosage form. 
b. Homogenization in nonaqueous media (Nanopure):  
 
Figure 2: Schematic Cartoon of the High-Pressure 
Homogenization Process. 
Nanopure is nothing but suspensions that are homogenized 
in water-free media or water mixtures like PEG 400, PEG 
1000 etc. The homogenization can be done at room 
temperature and sometimes at 00C and below freezing point 
that is -200C, hence it is known as “deep freeze” 
homogenization. The results obtained were comparable to 
Disso Cubes and hence can be used effectively for 
thermolabile substances at milder conditions5,7. 
c. Nanoedge:  
The basic principles of Nanoedge are the same as that  of  
precipitation  and  homogenization.The  drug  is dissolved in  
an organic  solvent  and this solution is mixed with a 
miscible anti-solvent for precipitation. In the water-solvent 
mixture, because of low solubility the drug 
precipitates.Nanoedge technology involves the combination 
of both precipitation and homogenization. The basic 
principle of this method is same as that of precipitation and 
homogenization. The major disadvantage of precipitation 
technique such as crystal growth and longterm stability can 
be minimized by using the Nanoedge technology. Particles of 
smallersize and better stability in short time can be 
achieved5, 7.  
d. Nanojet:  
It is also known  as opposite stream technology, uses a 
chamber where a stream of suspension is divided into two 
or more parts, which colloid with each other at high 
pressure, due to the high shear forcesproduced during the 
process particle size is reduced7.  Due to high shear force 
produced during the process which results in particle size 
reduction. The M110L and  M110S microfluidizers 
(Microfluidics) equipments used for this purpose1,5,7. 
B. Dry cogrinding: 
Since last years, nanosuspensions are prepared through wet 
grinding processes by using pearl ball mill. Nowadays, 
various technologies has beendeveloped for preparation of 
nananosuspensions such as dry milling methods.Stable 
nanosuspensions are prepared by using dry grinding of 
poorly soluble drug with soluble polymers and copolymers 
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C. Precipitation Method: 
 
Figure 3: schematic diagram for precipitation method 
Precipitation method is a common method used to prepare 
submicron particles of poorly soluble drugs. In this method, 
firstly the drug is dissolved in solvent and then solution is 
mixed with solvent to which drug is insoluble in the 
presence of surfactant which will results in precipitation. 
Rapid addition of solution to such solvent (generally water) 
leads to rapid supersaturation of drug in the solution, and 
formation of ultrafine amorphous or crystalline drug. This 
method involves formation of nuclei and crystal growth 
which are mainly dependent on temperature. High 
nucleation rate and low crystal growth rate are primary 
requirements for preparing a stable suspension with 
minimum particle size1,7. 
APPLICATINS OF NANOSUSPENSIONS 
1. Nanosuspension for pulmonary drug delivery 
Pulmonary drug delivery to the lung represents a non- 
invasive possibility for local and systemic therapies. Direct 
pulmonary delivery in humans can be achieved using an 
aerosol generated by either an inhaler or nebulizer. The local 
application of therapeutic agents to the lungs has the 
advantages of an increased selectivity and high local 
concentration over other routes of administration, thus 
being the prevalent approach for the treatment of 
respiratory diseases. On the other hand, pulmonary route 
has gained growing attention as a potential way for systemic 
drug delivery, due to the large alveolar surface area, the 
thinness of the epithelial barrier and extensive 
Vascularization suitable for drug absorption13. 
2. Nanosuspension for ocular drug delivery 
The nanocrystalline form leads to an increased saturation 
solubility of the drug in thetopical dosage form, thus 
enhancing the diffusion of the drug into the skin.The topical 
ocular administration of drugs is the most common route to 
provide treatment for both superficial and intraocular 
diseases. Depending on the target sites of the different 
ocular pathologies, drugs either need to be retained at the 
cornea and/or conjunctiva(e.g. conjunctivitis, blepharitis, 
keratitis sicca) or cross these barriers and reach the internal 
structures of the eye (e.g., glaucoma, uveitis). For ocular 
delivery of poorly soluble drugs, because the organic 
solvents and extreme pH should be avoid when considering 
the high sensitivity of the eye tissue, preparations such as 
microsuspensions and ointments have been developed to 
meet the therapeutic requires13,14. 
3. Nanosuspension for topical/dermal drug delivery 
Dermal nanosuspensions are mainly of interest if 
conventional formulation approaches fail.The 
nanocrystalline form leads to an increased saturation 
solubility of the drug in thetopical dosage form, thus 
enhancing the diffusion of the drug into the skin. The 
increased saturation solubility leads to “supersaturated” 
formulations, enhancing the drug absorption through the 
skin. This effect can further be enhanced by the use of 
positively charged polymers as stabilizers for the drug 
nanocrystals. The opposite charge leads to an increased 
affinity of the drug nanocrystals to the negatively charged 
stratum corneum. Among the various strategies for 
enhancing dermal application, nanocrystals can be 
considered a rather new but highly interesting approach13,14. 
4. Distinct Drug Delivery  
Nanosuspensions are compatible for targeting precise 
organs considering that of their surface houses. Along with 
this, it is anything but difficult to modify in vivo conduct by 
altering the stabilizer. The drug will probably be taken up by 
the mononuclear phagocytic method which allows area-
particular delivery. This can be utilized for focusing on 
antifungal, antimycobacterial, or antileishmanial 
pharmaceuticals to macrophages6, 13. 
5. Target Drug Delivery 
The need to target drugs to specific sites is increasing day by 
day as a result of therapeutic and economic factors. 
Nanosuspensions can also be used for targeted delivery as 
their surface properties and in vivo behavior can easily be 
altered by changing the stabilizer. Their versatility, ease of 
scale up and commercial product enable the development of 
commercial viable nanosuspensions for targeted delivery 8, 
13, 14. 
6. Parenteral Administration 
The parenteral route is an invasive route. Parenteral 
administration of drugs is critical and often associated with 
the problems such as the limited number of acceptable 
excipients, restrictions on the quantities of excipients 
approved for parenteral use, the stringent requirements of 
the aseptic production process, safety issues, patient 
noncompliance and biological problems such as allergic 
reactions and thrombophlebitis. Nanosuspensions can be 
administered via different parenteral administration routes 
ranging from intra-articular via intraperitonal to 
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intravenous injection. For administration by the parenteral 
route, the drug either has to be solubilized or has 
particle/globule size below 5 μm to avoid capillary 
blockage8, 14. 
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